DBV Technologies’ $306.9M Private Placement Backed by Paul Hastings
Deal News | Mar 28, 2025 | Paul Hastings
Paul Hastings LLP, a prominent law firm, played a pivotal role as an advisor to LifeSci Capital LLC, Van Lanschot Kempen N.V., and Van Lanschot Kempen (USA) Inc. These firms acted as placement agents for DBV Technologies in a significant private placement transaction valued at up to $306.9 million. The deal aims to further the development of DBV’s Viaskin peanut patch, an innovative treatment for pediatric peanut allergies. The legal team from Paul Hastings was led by Seo Salimi, Co-head of Equity Capital Markets and Co-chair of the Corporate Life Sciences Group, and partner Will Magioncalda. Paul Hastings is renowned for its expertise across various key practices and is considered a top firm globally in catering to investment banks, asset managers, and corporations.
Sectors
- Biotechnology
- Legal Services
- Capital Markets
Geography
- United States – DBV Technologies is listed on the Nasdaq, and Paul Hastings' role involves entities like LifeSci Capital LLC and Van Lanschot Kempen (USA) Inc., which operate in the US.
- Netherlands – Van Lanschot Kempen N.V., one of the placement agents involved, is based in the Netherlands.
Industry
- Biotechnology – DBV Technologies operates in the biotechnology sector, focusing on the development of treatments for allergies, including its Viaskin peanut patch.
- Legal Services – Paul Hastings LLP provides legal services as an advisor in this transaction, representing the placement agents in the private placement for DBV Technologies.
- Capital Markets – The transaction involves a private placement which is a significant activity within capital markets, involving financial structuring and investment aspects.
Financials
- $306.9 million – The transaction value of the private placement for DBV Technologies.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| DBV Technologies | Target Company | Company | A biotechnology firm working on the Viaskin peanut patch for pediatric peanut allergies. |
| Paul Hastings LLP | Legal Advisor | Company | A law firm advising the placement agents involved in the DBV Technologies private placement. |
| LifeSci Capital LLC | Placement Agent | Company | One of the placement agents in the DBV Technologies private placement. |
| Van Lanschot Kempen N.V. | Placement Agent | Company | A financial services company involved as a placement agent in this transaction. |
| Van Lanschot Kempen (USA) Inc. | Placement Agent | Company | Serves as a placement agent for the DBV Technologies private placement in the US. |